Abstract Background Pancreatic cancer is one of the deadliest human malignancies, with few therapeutic options. Re-activation of embryonic signaling pathways is commonly in human pancreatic cancer and provided rationale to explore inhibition of these pathways therapeutically. Notch signaling is important during pancreatic development, and it is re-activated in pancreatic cancer. The functional role of Notch signaling during pancreatic carcinogenesis has been previously characterized using both genetic and drug-based approaches. However, contrasting findings were reported based on the study design. In fact, Notch signaling has been proposed to act as tumor-promoter or tumor-suppressor. Given the...
AbstractThe Notch signaling pathway regulates embryonic development of the pancreas, inhibiting prog...
AbstractBackgroundGlycogen synthase kinase-3 (GSK-3) can act as either a tumour promoter or suppress...
<div><p>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a high rate of metasta...
Pancreatic cancer is one of the most fatal malignancies lacking effective therapies. Notch signaling...
AbstractNotch signaling regulates cell fate decisions in a wide variety of adult and embryonic tissu...
Pancreatic cancer is one of the most fatal malignancies lacking effective therapies. Notch signaling...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive human cancers, with a five-yea...
K-ras is the most commonly mutated oncogene in pancreatic cancer and its activation in murine models...
<div><p>Background</p><p>Pancreatic cancer stem cells (CSCs) represent a small subpopulation of panc...
BackgroundPancreatic cancer stem cells (CSCs) represent a small subpopulation of pancreatic cancer c...
<div><p>Pancreatic ductal adenocarcinoma is believed to arise from precursor lesions termed pancreat...
PURPOSE: Aberrant activation of the Notch signaling pathway is commonly observed in human pancreatic...
Pancreatic ductal adenocarcinoma is believed to arise from precursor lesions termed pancreatic intra...
K-ras is the most commonly mutated oncogene in pancreatic cancer and its activation in murine models...
IMPORTANCE OF THE FIELD: With some 220,000 new cases/year in the world, pancreatic adenocarcinoma is...
AbstractThe Notch signaling pathway regulates embryonic development of the pancreas, inhibiting prog...
AbstractBackgroundGlycogen synthase kinase-3 (GSK-3) can act as either a tumour promoter or suppress...
<div><p>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a high rate of metasta...
Pancreatic cancer is one of the most fatal malignancies lacking effective therapies. Notch signaling...
AbstractNotch signaling regulates cell fate decisions in a wide variety of adult and embryonic tissu...
Pancreatic cancer is one of the most fatal malignancies lacking effective therapies. Notch signaling...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive human cancers, with a five-yea...
K-ras is the most commonly mutated oncogene in pancreatic cancer and its activation in murine models...
<div><p>Background</p><p>Pancreatic cancer stem cells (CSCs) represent a small subpopulation of panc...
BackgroundPancreatic cancer stem cells (CSCs) represent a small subpopulation of pancreatic cancer c...
<div><p>Pancreatic ductal adenocarcinoma is believed to arise from precursor lesions termed pancreat...
PURPOSE: Aberrant activation of the Notch signaling pathway is commonly observed in human pancreatic...
Pancreatic ductal adenocarcinoma is believed to arise from precursor lesions termed pancreatic intra...
K-ras is the most commonly mutated oncogene in pancreatic cancer and its activation in murine models...
IMPORTANCE OF THE FIELD: With some 220,000 new cases/year in the world, pancreatic adenocarcinoma is...
AbstractThe Notch signaling pathway regulates embryonic development of the pancreas, inhibiting prog...
AbstractBackgroundGlycogen synthase kinase-3 (GSK-3) can act as either a tumour promoter or suppress...
<div><p>Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a high rate of metasta...